bt_bb_section_bottom_section_coverage_image

Clonidine for ADHD: A New Trial

April 7, 2026by Chris Aiken, MD0
A nonstimulant option gets its first rigorous test in an Asian population

STUDY: Qian Y et al, J Child Adolesc Psychopharmacol 2026;00:000

STUDY TYPE: Randomized, double-blind, placebo-controlled trial

FUNDING: Xiamen LP Pharmaceutical Co., Ltd.

Background

Extended-release clonidine — an alpha-2 adrenergic agonist that tamps down norepinephrine signaling in the prefrontal cortex — is FDA-approved for ADHD in the U.S., and this is the first trial to test it in Chinese children.

The Study

This 6-week multicenter randomized controlled trial enrolled 75 children and adolescents ages 6–17 with DSM-5 ADHD, randomizing them 2:1 to once-daily extended-release clonidine (0.2 mg/day) or placebo. The primary outcome was change in total score on the ADHD symptom scale (SNAP-IV) at week 5.

The clonidine group improved significantly more than placebo on the SNAP-IV total score (–17.5 vs. –10.3; with a moderate effect size Hedges’ g = 0.69). Benefits appeared by week 1 and held through week 6. Inattention and hyperactivity/impulsivity subscales both improved. Roughly 70% of clonidine-treated patients were rated as responders versus 33% on placebo.

Somnolence was the most common side effect (26%), but no serious adverse events occurred and dropout was low at 5.3%.

Practice Implications
  1. Psych meds like antidepressants and antipsychotics are often less tolerable in Asian populations, so this study brings reassurance.
  2. However, clonidine is metabolized by CYP2D6, and this enzyme is slowed (poor) in 7% of Caucasians but only 1% of Asians, suggesting more side effects in Caucasians. Instead, Asians have high rates (40%) of intermediate metabolism at 2D6, and this doesn’t clearly change drug levels.
  3. If your patient has trouble tolerating clonidine, consider guanfacine (less sedation) or clonidine weekly patch (it was better tolerated than pill in a head-to-head trial of hypertension).
  4. Learn how to use clonidine and guanfacine — and the backstory behind their discovery — in our Carlat Podcast.

— Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report

What’s Your Take? Share in Comments
  1. How do you manage side effects on clonidine? Do you use XR, patch, or instant release? All at night or twice a day?

Leave a Reply

Your email address will not be published. Required fields are marked *